2021
Cancer Microbiology
DiMaio D, Emu B, Goodman AL, Mothes W, Justice A. Cancer Microbiology. Journal Of The National Cancer Institute 2021, 114: 651-663. PMID: 34850062, PMCID: PMC9086797, DOI: 10.1093/jnci/djab212.Peer-Reviewed Original ResearchConceptsDirect carcinogenic effectSpecific immune interactionsMiddle-income countriesCancer controlCancer preventionInfection controlImmune interactionsCancerCancer treatmentCarcinogenic effectsExposure reductionDrug developmentCancer formationPublic healthTreatmentHuman microbiomeCross-disciplinary trainingVaccineAntiviralsPreventionImportant roleNIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.
Pahwa S, Deeks S, Zou S, Tomitch N, Miller-Novak L, Caler E, Justice A, Sacktor N, Gabuzda D, Hunt PW, Brown T, Kurth A, Baral S, Mugavero M, Mayer KH, Mendenhall E, Detels R, Mutabazi V. NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2021, 86: 11-18. PMID: 33306561, PMCID: PMC7982002, DOI: 10.1097/qai.0000000000002528.Peer-Reviewed Original ResearchConceptsPotent antiretroviral therapyImplementation science researchBasic science researchAIDS comorbiditiesAntiretroviral therapyMiddle-income countriesClinical researchHealthy agingSyndemics researchHealth spanNIH workshopComorbiditiesComplicationsHIVPWHNormal lifespanCoinfectionIncome countriesNIHPressing gapsPotential prioritiesInvestigatorsPopulation researchRegimensWG members
2014
Observational Research on NCDs in HIV-Positive Populations
Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational Research on NCDs in HIV-Positive Populations. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2014, 67: s8-s16. PMID: 25117964, PMCID: PMC4317266, DOI: 10.1097/qai.0000000000000253.Peer-Reviewed Original ResearchConceptsNCD risk factorsNoncommunicable diseasesRisk factorsKey NCD risk factorsBurden of NCDsCost-effective prevention strategiesPrevention of NCDsEfficient care strategyIncomplete outcome ascertainmentHIV-positive populationModifiable risk factorsBurden of morbidityRisk of deathPopulation-based sampleHealth system levelClinical decision makingWeb of causationNCD comorbidityHIV-negativeHIV infectionMiddle-income countriesRandomized trialsOutcome ascertainmentHigh-income countriesPrevention strategies